Cargando…

SGLT2 Inhibitor, Canagliflozin, Attenuates Myocardial Infarction in the Diabetic and Nondiabetic Heart

The authors hypothesized that despite similar cardiovascular event rates, the improved cardiovascular survival from sodium glucose transporter 2 (SGLT2) inhibition, seen clinically, could be via a direct cytoprotective effect, including protection against myocardial ischemia/reperfusion injury. Lang...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lim, Ven G., Bell, Robert M., Arjun, Sapna, Kolatsi-Joannou, Maria, Long, David A., Yellon, Derek M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	MINI FOCUS ON SGLT2 INHIBITOR
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390729/ https://www.ncbi.nlm.nih.gov/pubmed/30847415 http://dx.doi.org/10.1016/j.jacbts.2018.10.002

Ejemplares similares

Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation and Study of Diabetic Nephropathy with Atrasentan: what was learned about the treatment of diabetic kidney disease with canagliflozin and atrasentan?
por: Fernandez-Fernandez, Beatriz, et al.
Publicado: (2019)

Empagliflozin Improves Diastolic Function in a Nondiabetic Rodent Model of Heart Failure With Preserved Ejection Fraction
por: Connelly, Kim A., et al.
Publicado: (2019)

Effect of sodium-glucose cotransporter 2 inhibitor on proximal tubular function and injury in patients with type 2 diabetes: a randomized controlled trial
por: Satirapoj, Bancha, et al.
Publicado: (2019)

Sodium-glucose cotransporter inhibitors: beyond glycaemic control
por: Vergara, Ander, et al.
Publicado: (2019)

Effects of empagliflozin on cardiovascular and renal outcomes in heart failure with reduced ejection fraction according to age: a secondary analysis of EMPEROR‐Reduced
por: Filippatos, Gerasimos, et al.
Publicado: (2022)

How can sodium–glucose cotransporter 2 inhibitors stimulate erythrocytosis in patients who are iron‐deficient? Implications for understanding iron homeostasis in heart failure
por: Packer, Milton
Publicado: (2022)

Dapagliflozin's effect on serum homocysteine in patients with hypertension complicated with insulin resistance
por: Yu, Xiaoqian, et al.
Publicado: (2023)

The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study
por: Herrington, William G, et al.
Publicado: (2018)

Effects of luseogliflozin on arterial properties in patients with type 2 diabetes mellitus: The multicenter, exploratory LUSCAR study
por: Kario, Kazuomi, et al.
Publicado: (2020)

Safety and efficacy of empagliflozin in elderly Japanese patients with type 2 diabetes mellitus: A post hoc analysis of data from the SACRA study
por: Okada, Kenta, et al.
Publicado: (2020)

Efficacy, safety and regulatory status of SGLT2 inhibitors: focus on canagliflozin
por: Haas, B, et al.
Publicado: (2014)

Deconvoluting Kinase Inhibitor Induced Cardiotoxicity
por: Lamore, Sarah D., et al.
Publicado: (2017)

Differential effect of canagliflozin, a sodium–glucose cotransporter 2 (SGLT2) inhibitor, on slow and fast skeletal muscles from nondiabetic mice
por: Otsuka, Hiroko, et al.
Publicado: (2022)

Acute Myocardial Infarction and Papillary Muscle Rupture in the COVID-19 Era
por: Atreya, Auras R., et al.
Publicado: (2020)

Rare and Complex Case Mimics Acute Myocardial Infarction: The Importance of Multimodality Imaging
por: Payne, Abby, et al.
Publicado: (2021)

Acute Myocardial Infarction With Cardiogenic Shock Due to Pericardial Constriction and Multivessel Coronary Obstruction
por: Schaikewitz, Matthew F., et al.
Publicado: (2020)

Scared to Death: Emotional Stress Causing Fatal Myocardial Infarction With Nonobstructed Coronary Arteries in Women
por: Aimo, Alberto, et al.
Publicado: (2020)

Ventricular Septal Rupture Complicating Delayed Acute Myocardial Infarction Presentation During the COVID-19 Pandemic
por: Alsidawi, Said, et al.
Publicado: (2020)

ST-Segment Elevation Myocardial Infarction Care During COVID-19: Losing Sight of the Forest for the Trees
por: Rodriguez-Leor, Oriol, et al.
Publicado: (2020)

Surge in Delayed Myocardial Infarction Presentations: An Inadvertent Consequence of Social Distancing During the COVID-19 Pandemic
por: Shah, Kulin, et al.
Publicado: (2020)

Collateral Damage: Medical Care Avoidance Behavior Among Patients With Myocardial Infarction During the COVID-19 Pandemic
por: Moroni, Francesco, et al.
Publicado: (2020)

Siblings With Familial Dwarfism Presenting With Acute Myocardial Infarction at Adolescence
por: Chung, Hyun, et al.
Publicado: (2021)

Canagliflozin, an SGLT2 inhibitor, attenuates the development of hepatocellular carcinoma in a mouse model of human NASH
por: Shiba, Kumiko, et al.
Publicado: (2018)

Mitochondrial cyclophilin-D as a potential therapeutic target for post-myocardial infarction heart failure
por: Lim, Shiang Y, et al.
Publicado: (2011)

Acute Adult-Onset Kawasaki Disease Complicated by Coronary Artery Aneurysms, Thrombosis, and ST-Segment Elevation Myocardial Infarction
por: Bratincsak, Andras, et al.
Publicado: (2021)

Cardiac Tamponade in a Patient With Myocardial Infarction and COVID-19: Electron Microscopy
por: García-Cruz, Edgar, et al.
Publicado: (2020)

Rare Case of Selenite Poisoning Manifesting as Non–ST-Segment Elevation Myocardial Infarction
por: Stroikova, Vera, et al.
Publicado: (2021)

Small-Vessel Vasculitis After ST-Segment Elevation Myocardial Infarction: Clopidogrel or Amiodarone?
por: Lehr, Saskia, et al.
Publicado: (2022)

Acute Myocardial Infarction After Surgical Closure of Coronary Artery Fistula: Importance of Anticoagulant Therapy
por: Meng, Liping, et al.
Publicado: (2022)

Symptomatic Presentation of Acute Myocardial Infarction in Heart Transplantation Patients
por: Jain, Shashank, et al.
Publicado: (2021)

“Catch Me If You Can”: Recurrent ST-Segment Elevation Myocardial Infarction Due to Aortic Thrombus
por: Cai, Xinzhe James, et al.
Publicado: (2020)

Canagliflozin: A Novel SGLT2 Inhibitor for Type 2 Diabetes Mellitus
por: Kaushal, Shaveta, et al.
Publicado: (2014)

Use of the SGLT2 inhibitor canagliflozin for control of refractory equine hyperinsulinemia and laminitis
por: Kellon, Eleanor M., et al.
Publicado: (2022)

Ventricular Septal Rupture in 2 Patients Presenting Late after Myocardial Infarction during the COVID-19 Pandemic
por: Parikh, Malav, et al.
Publicado: (2020)

Electrocardiographic Recognition of Unprotected Left Main ST-Segment Elevation Myocardial Infarction: Looking Beyond aVR
por: González-Bravo, Diego H., et al.
Publicado: (2021)

Sarcoidosis Diagnosed by Myocardial Perfusion
por: Liu, Yan, et al.
Publicado: (2020)

An Uncommon Cause of ST-Segment Elevation Myocardial Infarction: Intramural Coronary Artery Hematoma After Blunt Chest Trauma
por: González-Bravo, Diego H., et al.
Publicado: (2020)

Glycemic variability is associated with myocardial damage in nondiabetic patients with ST-elevation myocardial infarction
por: Oka, Satoshi, et al.
Publicado: (2018)

Reducing myocardial infarct size: challenges and future opportunities
por: Bulluck, Heerajnarain, et al.
Publicado: (2016)

Mechanical Non-ST-Segment Elevation Myocardial Infarction Secondary to Left Ventricular Outflow Tract Pseudoaneurysm: A Unique Entity
por: Kumar, Jathinder, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4iv2mn264lab2s5k621d5b4tul